Skip to main content
. 2017 Sep 5;7:10504. doi: 10.1038/s41598-017-10692-5

Figure 4.

Figure 4

Fold-change in mRNA expression of P0 vs E12.5 NDCs for selected developmental pathways and immunohistochemical analysis of component growth factors at E12.5 and P0. (A) Fold-change in mRNA expression of Shh signaling pathway elements showing significant downregulation at P0. (B) SHH protein staining showing intense positive staining of the notochord at E12.5 and diffuse staining of the NP at P0. (C) Fold-change in mRNA expression of TGF-β pathway elements showing significant upregulation of both Tgfb1 and Tgfbr2 at P0. (D) TGF-β1 protein staining showing few positively stained notochord cells at E12.5, and widespread positive staining of NP cells and diffuse NP ECM staining at P0. (E) Fold-change in mRNA expression of IGF pathway elements showing significant upregulation of Igf1 at P0. (F) IGF-1 protein staining showing positive staining of the notochord at E12.5, and widespread positive staining of NP cells and diffuse NP ECM staining at P0. N = 4; all fold changes p < 0.05, P0 compared to E12.5, analyzed by DESeq2 and adjusted for false discovery rate. Refer to Fig. 2 for annotation of structural regions.